Radiosensitizers in pancreatic cancer-Preclinical and clinical exploits with molecularly targeted agents

被引:3
作者
Walker, Amanda J. [4 ]
Alcorn, Sara R. [4 ]
Narang, Amol K. [4 ]
Nugent, Katriana M. [5 ]
Wild, Aaron T. [2 ,3 ]
Herman, Joseph M. [1 ]
Tran, Phuoc T. [6 ]
机构
[1] Johns Hopkins Univ, Dept Radiat Oncol, Gastrointestinal Div, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[5] Johns Hopkins Univ Hosp, Dept Radiat Oncol & Mol Radiat Sci, Lab Phuoc Tran, Baltimore, MD 21287 USA
[6] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA
关键词
GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; RANDOMIZED PHASE-II; POTENT ANTITUMOR-ACTIVITY; HEAT-SHOCK RESPONSE; HSP90; INHIBITOR; RADIATION-THERAPY; STEREOTACTIC RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; TASK-FORCE;
D O I
10.1016/j.currproblcancer.2013.10.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:301 / 312
页数:12
相关论文
共 115 条
  • [1] Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy-Focus on Prostate Cancer
    Alcorn, Sara
    Walker, Amanda J.
    Gandhi, Nishant
    Narang, Amol
    Wild, Aaron T.
    Hales, Russell K.
    Herman, Joseph M.
    Song, Danny Y.
    DeWeese, Theodore L.
    Antonarakis, Emmanuel S.
    Tran, Phuoc T.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (07) : 14800 - 14832
  • [2] MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES
    ALMOGUERA, C
    SHIBATA, D
    FORRESTER, K
    MARTIN, J
    ARNHEIM, N
    PERUCHO, M
    [J]. CELL, 1988, 53 (04) : 549 - 554
  • [3] [Anonymous], 1987, Cancer, V59, P2006
  • [4] [Anonymous], 2012, Cancer Facts and Figures 2012, V2012
  • [5] NORMAL TISSUE-INJURY AFTER CANCER-THERAPY IS A LOCAL RESPONSE EXACERBATED BY AN ENDOCRINE EFFECT OF TGF-BETA
    ANSCHER, MS
    KONG, FM
    MURASE, T
    JIRTLE, RL
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1995, 68 (807) : 331 - 333
  • [6] TRANSFORMING GROWTH FACTOR-BETA-1 EXPRESSION IN IRRADIATED LIVER
    ANSCHER, MS
    CROCKER, IR
    JIRTLE, RL
    [J]. RADIATION RESEARCH, 1990, 122 (01) : 77 - 85
  • [7] The Clinical Development of Molecularly Targeted Agents in Combination With Radiation Therapy: A Pharmaceutical Perspective
    Ataman, Ozlem U.
    Sambrook, Sally J.
    Wilks, Chris
    Lloyd, Andrew
    Taylor, Amanda E.
    Wedge, Stephen R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (04): : E447 - E454
  • [8] Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
    Bao, Philip Q.
    Ramanathan, Ramesh K.
    Krasinkas, Alyssa
    Bahary, Nathan
    Lembersky, Barry C.
    Bartlett, David L.
    Hughes, Steven J.
    Lee, Kenneth K.
    Moser, A. James
    Zeh, Herbert J., III
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1122 - 1129
  • [9] EGFR-targeted anti-cancer drugs in radiotherapy:: Preclinical evaluation of mechanisms
    Baumann, Michael
    Krause, Mechthild
    Dikomey, Ekkehard
    Dittmann, Klaus
    Doerr, Wolfgang
    Kasten-Pisula, Ulla
    Rodemann, H. Peter
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 83 (03) : 238 - 248
  • [10] Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions
    Bentzen, Soren M.
    Harari, Paul M.
    Bernier, Jacques
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (03): : 172 - 180